|
Historical Conference Archive
Quick Links:
2007 Conferences
2006 Conferences
2005 Conferences
2004 Conferences
2007
SECTION OF CARDIOLOGY
GRAND ROUNDS CONFERENCES
2007
January:
Robert M. Zwolak, M.D., Ph.D.
DHMC
AAA: Rationale for Screening and the SAAAVE Act of 2006
Stacie A. Luther, M.D., M.S.P.H.
University of Colorado Health Sciences Center
In search of the ideal tool to monitor heart failure
Aaron Kaplan, M.D.
DHMC
Development of a novel side-branch stent: Carving a path from concept to first clinical use: The perspective of a clinician/entrepreneur
February:
Frances C. Munkenbeck, M.D.
Shaw Heart Center of Portland, OR
Cardiocerebral resuscitation: New developments in resuscitation science
Tzung K. Hsiai, M.D., Ph.D.
University of Southern California School of Engineering & School of Medicine
Fluid shear stress and vascular oxidative stress: Implication for micro- and nano-technology
Richard J. Powell, M.D.
DHMC
Update on minimally invasive treatment of lower extremity arterial occlusive disease
March:
Timothy A. Beaver, M.D.
Kansas Cardiovascular Center
Echo-guided optimization of the biventricular pacemaker
Peter M. Morganelli, Ph.D.
DHMC
Role of immune complexes in atherosclerosis
John R. Butterly, M.D.
DHMC
CMS Initiatives: P4P
Calum A. MacRae, M.B., Ch.B.
Harvard Medical School
Genetic approaches to common cardiovascular disease in zebrafish and man
April:
Edward P. Gerstenfeld, M.S., M.D.
University of Pennsylvania school of Medicine
Ablation of atrial fibrillation: Past, present and future
May:
Justin D. Pearlman, M.D., M.E., Ph.D., M.A.
DHMC
A non-invasive look at myocardial oxygen influx and extraction
Robert S. Ross, M.D.
University of California – San Diego
Taking a bit of the idiopathic out of cardiomyopathy: The role of mechanotransduction/cytoskeletal molecules in the cardiac myocyte
Steven B. Feinstein, M.D.
Rush University Medical Center
Non-invasive imaging and treatment for atherosclerosis
David J. Malenka, M.D.
DHMC
Evidence-based anticoagulation of the patient with ACS: Building consensus
June:
John Hwa, MBBS, Ph.D.
DHMC
Prostacyclin receptor and cardiovascular disease: hIP, SNiP, COX and Vioxx
Bruce W. Andrus, M.D.
DHMC
Diabetic cardiovascular disease: From bench to starting lineup and back
Nicholas Shworak, M.D., Ph.D.
DHMC
Does anticoagulant heparin sulfate inhibit vascular inflammation?
September:
October:
November:
December:
[Back to Top]
2006
SECTION OF CARDIOLOGY
GRAND ROUNDS CONFERENCES
2006
January:
Donald S. Baim, M.D.
Harvard Medical School
Percutaneous valve repair and replacement
Richard J. Powell, M.D.
DHMC
Treatment of extracranial carotid artery occlusive disease
Aaron Kaplan, M.D.
DHMC
When you come to a fork in the road…FIX IT – New approaches to coronary bifurcations
Harold M. Swartz, M.D., Ph.D.
DHMC/DMS
Repeated measurements of tissue oxygen using in vivo EPR in isolated hearts, in intact animals, and in the human foot
February:
Bruce J. Friedman, M.D.
DHMC
Live Free or Die
Mark L. Greenberg, M.D.
DHMC
Small, medium, and Large: Afib research at Dartmouth
Barbara R. Gerling, M.D.
DHMC
Pregnancy and the Heart
March:
Stephen E. Epstein, M.D.
Washington Hospital Center
Cell therapy for angiogenesis: Current and future directions
Jon W. Wahrenberger, M.D.
DHMC
Ashes to ashes: Tobacco and its cardiovascular consequences
Salvatore Costa, M.D.
DHMC
Prevention of coronary disease: Do we want to be ahead of the pay-for-performance curve?
John R. Laird Jr., M.D.
Washington Cardiovascular Center
Update on peripheral vascular interventions
Bruce D. Hettleman, M.D.
DHMC
Cardiac resynchronization: Can we improve on current approaches?
April:
Andrew Dowson, M.B., B.S.
Kings College Hospital, London, England
Patent foramen ovale and migraine
Edward Catherwood, M.D.
DHMC
Microsystems in Cardiology: The ICCU Redesign Project
May:
Andrew T. Torkelson, M.D.
DHMC
Avoiding senescence -or- Can we be here and still have hair after 90?
C. Michael Gibson, M.S., M.D.
Beth Israel Deaconess Medical Center
State of the art in revascularization therapy in acute coronary syndromes
John E. Jayne, M.D.
DHMC
Left Main PCI Program
June:
Charles L. Haffajee, M.D.
Tufts University School of Medicine
Overview of AF therapy and the status of AF ablation
John A. Baron, M.D.
DHMC
Update on Vioxx
September:
Arnold M. Katz, M.D.
U Conn Health Center
Heart Failure: A Primer
Edward Catherwood, M.D.
DHMC
Review of Cardiology Fellowship Program
Michael Simons, M.D.
DHMC
Genetics of coronary disease
Robert Palac, M.D.
DHMC
Real-Time 3D imaging: Applications and Future Directions
October:
Gary H. Gibbons, M.D.
Morehouse School of Medicine – Atlanta GA
Cardiovascular Genomics: Implications & Applications
November:
AHA 2006 Preview (no CME credit)
(held in two sessions)
Alan T. Kono, M.D.
DHMC
Heart failure disease management: Can we impact outcomes with
low-tech/high-tech strategies?
December:
Craig Thompson, M.D.
DHMC
Stent thrombosis and outcomes in the drug eluting stent era
Navin Kapur, M.D.
Johns Hopkins
Endomyocardial coupling in heart failure: The role of Transforming Growth Factor Beta
[Back to Top]
2005
SECTION OF CARDIOLOGY
GRAND ROUNDS CONFERENCES
2005
January:
Gegory M. Lanza, MD, PhD
Washington University Medical School
Molecular imaging and targeted drug delivery: New paradigm for cardiovascular medicine
Nathaniel W. Niles II, MD
DHMC
Acute myocardial infarction: Results from the DHMC Registry
John F. Keaney Jr., MD
Boston University School of Medicine
Whittaker Cardiovascular Institute
Oxidative stress and cardiovascular disease: Fact or fantasy
Robert O. Bonow, MD
Northwestern University Medical School
Pathogenesis and management of aortic valve disease
February:
Jorge Plutzky, MD
Harvard Medical School
Diabetic atherosclerosis: New targets, new pathways
Peter Holzberger, MD
DHMC
VT Ablation
Michael Simons, MD
DHMC
Arteriogenesis
March:
Robert J. de Winter, MD, PhD
University of Amsterdam
Management strategies in high-risk NSTEMI
Joseph A. Vita, MD
Boston University
Tickling tiny bubbles tells the tissue’s tale
David DeNofrio, MD
Tufts-New England Medical Center
ACORN support device: IS it ready for prime time?
John F. Robb, MD
DHMC
DASH to the finish!
April:
Roger J. Hajjar, M.D.
Harvard Medical School
Targeted gene transfer in heart failure
Arnold M. Katz, MD
University of Connecticut
Molecular mechanisms in the pathogenesis of clinical arrhythmias
Flordeliza S. Villanueva, MD
University of Pittsburgh
Targeted ultrasound imaging of endothelial dysfunction
May:
Geoffrey S. Ginsburg, MD, PhD
Duke University
Prospects for personalized cardiovascular care: The impact of genomics
John Hwa, MBBS, PhD
DHMC
Pharmacogenetics and cardiovascular disease: The times they are a changing
Daniela Tirziu, PhD
Masahiro Murakami, MD, PhD
DHMC
Fellow Research Presentations
June:
Justin D. Pearlman, MD, ME, PhD, MA
DHMC
Carbogen study of the heart
David J. Malenka, MD
DHMC
PCI: Insights into regional practices and outcomes
Michael Duong, MD
Dmitri Baklanov, MD
DHMC
Renal disease in cardiovascular medicine
Catheter guidance with 3D Echo
September:
John Elefteriades, MD
Yale University School of Medicine
Thoracic aortic aneurysm: Reading the enemy’s playbook
Ebo D. deMuinck, MD, PhD
DHMC
Cardiac regenerative therapy: Seeing is believing
Tristram Bahnson, MD
Duke University Medical Center
AF Ablation; An evolving therapy
Beth Wolf, MBA
DHMC
Getting paid for what you do….or NOT!
October:
Richard J. Comi, MD
DHMC
Intensive glucose control in the hospital: Science and outcomes
Prof. Ulrich Sigwart
University Hospital of Geneva, Switzerland
Pfizer/ACC Visiting Professor
Nonsurgical myocardial reduction therapy for the treatment of hypertrophic cardiomyopathy: From idea to standard of care
November:
Ebo deMuinck, MD, PhD; Stephen D. Surgenor, MD; Jeremiah Brown, PhD;
Masahiro Murakami, MD, PhD; and Thomas W. Chittenden, PhD
DHMC
American Heart Association Scientific Sessions 2005 Presentations
Michael E. Mendelsohn, MD
Tufts University School of Medicine
Estrogen actions on the cardiovascular system
December:
Elazer R. Edelman, MD, PhD
Harvard Medical School
Massachusetts Institute of Technology
Cardiovascular tissue engineering: Lessons from devices and vascular biology
[Back to Top]
2004
SECTION OF CARDIOLOGY
GRAND ROUNDS CONFERENCES
2004
January:
Robert Foote, MD and K-T Jerry Yeo, PhD
DHMC
BNP Project Presentation
David Kass, MD
Johns Hopkins
Cardiac resynchronization: New insights
Richard J. Cohen, MD, PhD
Harvard-MIT Division of Health Sciences & Technology
Microvolt T wave alternans testing to reduce sudden cardiac death
Alan Kono, MD
DHMC
BNP, for you and me, how happy will we be?
February:
H. Robert Superko, MD
Cholesterol, Genetics & Heart Disease Institute, Burlingame CA
A sophisticated approach to secondary prevention
Kenneth D. Bloch, MD
Mass General Hospital
Nitric oxide synthases in ventricular remodeling: Insights gained from genetically-modified mice
Paul M. Ridker, MD
Brigham and Women’s Hospital
Inflammation, C-reactive protein, and atherothrombosis: Can we better predict heart attack and stroke?
Daniel J. O’Rourke, MD
DHMC
Biomarkers and atherosclerosis
March:
Ralph A. Kelly, MD
Genzyme Corporation
Harnassing the response to hypoxia: H1F-1alpha as a therapeutic transgene for ischemic valvular disease
Robert Palac, MD
DHMC
Tickling tiny bubbles tells the tissue’s tale
David J. Malenka, MD
DHMC
PCI without onsite cardiac surgery: To be or not to be?
Justin Pearlman, MD, ME, PhD
DHMC
Microvascular disease assessment
April:
Craig Thompson, MD
DHMC
Emerging Technologies for Peripheral Arterial Disease
5:00 PM - Auditorium G
Andrew Torkelson, MD
DHMC
All Cholesterols Are Created Equal, But Some Are More Equal Than Others
Richard Powell, MD
DHMC
Minimally Invasive Treatment of Peripheral Vascular Disease
G. William Dec, Jr., MD
Mass General Hospital
Idiopathic Dilated Cardiomyopathy: New Insights into Pathogenesis and Treatment
Bruce R. Brodie, MD
U North Carolina/Moses Cone Memorial Hospital
Impact of Time Delays on Outcomes with Primary PCI for AMI: Implications for Patient Triage
May:
Ary Goldberger, MD
Beth Israel Deaconess Medical Center
Fractals, Chaos & Complexity: What/Why Every Cardiologist Needs to Know about Nonlinear Dynamics
John E. Jayne, MD
DHMC
Epistemology of CTOs
John F. Robb, MD
Marvin Doyley, PhD
DHMC
IVUS and Arterial Elastography
June:
Armin Helisch, MD
DHMC
Collateral Arteries: Where do they come from? How do they grow?
Bradford C. Berk, MD, PhD
University of Rochester
Plaque Erosion: Endothelial Cell Apoptosis as a Cause of MI
Joseph Loscalzo, MD, PhD
Boston University School of Medicine
Homocysteine and Atherothrombosis: Mechanisms, Controversies, and Future Directions
James DeVries, MD
Dmitri Baklanov, MD, PhD
DHMC
Research Presentations
September:
Nicholas Shworak, MD, PhD
DHMC
Introduction to Molecular Cardiology: Gene Expression and Pathologic Cardiac Hypertrophy
Jason H. Moore, PhD
DMS
Bioinformatics Strategies for Cardiovascular Genetics
Joseph M. Smith, MD, PhD
Senior Vice President & CMO – Guidant Corporation
The Future of Heart Rhythm Management
Edward Catherwood, MD
DHMC
Pulmonary Hypertension: Early Steps in the Long March Towards Effective Treatment
October:
Professor Peter Carmeliet
Center for Transgene Technology & Gene Therapy, Belgium
Genetic analysis of angiogenesis: Role and therapeutic implications for the VEGF family
Peter Fitzgerald, MD, PhD
Stanford University School of Medicine
PCI: New Technology for a New Century
November:
Aaron Kaplan, MD
DHMC
3D2 Symposium Update
John A. Baron, MD
DHMC
The Vioxx Withdrawal
Laurence Epstein, MD
Brigham and Women’s Hospital/Harvard Medical School
Advances in Catheter Ablation of Cardiac Arrhythmias
December:
Paul Steiner, MD
DHMC
Non-Pharmaceutical Treatments of Atrial Fibrillation
C. Michael Gibson, MD
Beth Israel Deaconess Medical Center/Harvard Medical School
Treatment of the Microvasculature
Jonathan Lindner, MD
University of Virginia Medical School
Molecular Imaging of Angiogenesis
[Back to Top]
|
